Zeltiq Aesthetics (NASDAQ: ZLTQ) is one of 87 publicly-traded companies in the “Advanced Medical Equipment & Technology” industry, but how does it weigh in compared to its peers? We will compare Zeltiq Aesthetics to similar companies based on the strength of its institutional ownership, profitability, risk, analyst recommendations, dividends, valuation and earnings.

Earnings and Valuation

This table compares Zeltiq Aesthetics and its peers revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Zeltiq Aesthetics N/A N/A N/A
Zeltiq Aesthetics Competitors $2.13 billion $221.25 million 2.53

Zeltiq Aesthetics’ peers have higher revenue and earnings than Zeltiq Aesthetics. Zeltiq Aesthetics is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

51.1% of shares of all “Advanced Medical Equipment & Technology” companies are owned by institutional investors. 15.6% of Zeltiq Aesthetics shares are owned by company insiders. Comparatively, 18.7% of shares of all “Advanced Medical Equipment & Technology” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and price targets for Zeltiq Aesthetics and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zeltiq Aesthetics 0 8 1 0 2.11
Zeltiq Aesthetics Competitors 267 1867 3359 108 2.59

Zeltiq Aesthetics presently has a consensus price target of $56.83, suggesting a potential upside of Infinity. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 7.50%. Given Zeltiq Aesthetics’ higher probable upside, equities analysts clearly believe Zeltiq Aesthetics is more favorable than its peers.


This table compares Zeltiq Aesthetics and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Zeltiq Aesthetics 9.78% 31.74% 20.11%
Zeltiq Aesthetics Competitors -299.57% -36.17% -12.71%


Zeltiq Aesthetics peers beat Zeltiq Aesthetics on 6 of the 10 factors compared.

Zeltiq Aesthetics Company Profile

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.

Receive News & Ratings for Zeltiq Aesthetics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.